HZNP — Horizon Therapeutics Public Limited Company

NASDAQ · Healthcare · Drug Manufacturers - General

Company fundamentals

MetricCached value
Price (USD)116.3
Market cap (USD)26,602,828,000
P/E51.01
ROE (%)10.7
Net profit margin (%)14.39
Revenue growth (%)12.48
Dividend yield (%)0

Price last refreshed: .

Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.

About Horizon Therapeutics Public Limited Company

Available company fundamentals for HZNP in Drug Manufacturers - General. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.